References
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al (2015) American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133.
Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552.
Mete O, Rotstein L, Asa SL (2010) Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 17:386–391.
Asioli S, Erickson LA, Righi A, Lloyd RV (2013) Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44:320–328.
Khoo MLC, Freeman JL, Witterick IJ, Irish JC, Rotstein LE, Gullane PJ, Asa SL (2002) Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 128:253-257.
Khoo MLC, Beasley NJP, Ezzat S, Freeman JL, Asa SL (2002) Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastasis in papillary thyroid carcinoma. J Clin Endocrinol Metab 87:1814-1818.
Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N (2008) Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters. Croat Med J 49:643–649.
Londero SC, Godballe C, Krogdahl A, Bastholt L, Specht L, Sørensen CH, et al (2008) Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Acta Oncol 47:451–457.
Cheng S, Serra S, Mercado M, Ezzat S, Asa SL (2011) A High-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res 17:2385-2394
Dencic TMI, Savin SB, Selemetjev SA, Paskas SD, Zivaljevic VR, Bozic VD, et al (2015) Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma. Pathol Oncol Res 21:735–742.
Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690.
Dettmer MS, Schmitt A, Steinert H et al. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 2015; 22(3):419-429.
Bullock M, Ren Y, O’Neill C, Gill A, Aniss A, Sywak M, et al (2015) TERT Promoter Mutations Are a Major Indicator of Recurrence and Death due to Papillary Thyroid Carcinomas. Clin Endocrinol [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Wang, T., Blumer, I., Boerner, S. et al. Synchronous Papillary Carcinoma of Thyroid and Lung. Endocr Pathol 27, 268–270 (2016). https://doi.org/10.1007/s12022-016-9435-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-016-9435-6